Cargando…
Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study
INTRODUCTION: Kukoamine B (KB) is a novel sepsis therapeutic drug targeting lipopolysaccharide and CpG DNA. This study aims to evaluate the safety, tolerability, and pharmacokinetic (PK) profile of multiple doses of KB in healthy volunteers. METHODS: Healthy volunteers were randomized at a 1:1:1:1 r...
Autores principales: | Zhao, Qian, Liu, Hongzhong, Wang, Zhenlei, Wang, Teng, Cui, Cheng, Wang, Huanhuan, Li, Lili, Zhong, Wen, Jiang, Ji, Dong, Kai, Chen, Shuai, Jin, Chunyan, Hu, Pei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10271881/ https://www.ncbi.nlm.nih.gov/pubmed/37233875 http://dx.doi.org/10.1007/s12325-023-02521-1 |
Ejemplares similares
-
Exposure-Response Modeling to Support Dosing Selection for Phase IIb Development of Kukoamine B in Sepsis Patients
por: Wang, Huanhuan, et al.
Publicado: (2021) -
Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10‐2474: A Double‐Blind, Randomized, Placebo‐Controlled Study in Healthy Volunteers
por: Rocha, José‐Francisco, et al.
Publicado: (2021) -
Safety, Tolerability and Pharmacokinetics of FAAH Inhibitor V158866: A Double-Blind, Randomised, Placebo-Controlled Phase I Study in Healthy Volunteers
por: Pawsey, Stephen, et al.
Publicado: (2016) -
Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial
por: Pitchford, Lisa M., et al.
Publicado: (2020) -
Safety, tolerance, and pharmacokinetics of salvianolic acid B in healthy Chinese volunteers: A randomized, double-blind, placebo-controlled phase 1 clinical trial
por: Cheng, Junlin, et al.
Publicado: (2023)